This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract has a ceiling value of $2,420.70 and runs through March 28, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HAVRIX 1,440 unit/mL syringes, with a total ceiling value of $16,541.45 and a period of performance through June 9, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML. The contract has a ceiling value of $95,105.97 and a completion date of May 30, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a total ceiling value of $3,215.14 and is a firm fixed price delivery order with a period of performance through May 9, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, with expertise...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,323.40, is for the delivery of HAVRIX 1,440 UNIT/ML SYRINGE medication. The contract is a Firm Fixed Price, non-set-aside award with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of HAVRIX 1,440 unit/mL syringes. The contract has a firm fixed price of $2,228.75 and an ultimate completion date of July 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide these critical medical supplies to support military treatment facilities and other federal healthcare providers. The contract is not designated as a...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of HAVRIX 720 unit/0.5 ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $1,175.94 and an ultimate completion date of August 30, 2024. This contract is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $1,143.30. The contract has a firm fixed price pricing type and an ultimate completion date of May 6, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of HAVRIX 1,440 UNIT/ML SYRINGE medical products. The award, valued at $5,953.53, has a firm fixed-price contract type and an ultimate completion date of August 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of essential medical commodities to various government agencies and healthcare programs through its...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of HAVRIX 1,440 UNIT/ML SYRINGE, a pharmaceutical product. The contract has a ceiling value of $1,905.50 and an ultimate completion date of July 25, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds several Indefinite...